ArticleBone marrow transplantation2019

A retrospective comparison of allogenic and autologous chimeric antigen receptor T cell therapy targeting CD19 in patients with relapsed/refractory acute lymphoblastic leukemia.

Yongxian Hu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.